Tehran University of Medical Sciences

Science Communicator Platform

Stay connected! Follow us on X network (Twitter):
Share this content! On (X network) By
Correction To: Erk/Hif-1Α/Vegf Pathway: A Molecular Target of Elabela (Ela) Peptide for Attenuating Cardiac Ischemia–Reperfusion Injury in Rats by Promoting Angiogenesis (Molecular Biology Reports, (2022), 49, 11, (10509-10519), 10.1007/S11033-022-07818-Y) Publisher Pubmed



Rakhshan K1 ; Sharifi M2, 3 ; Ramezani F2 ; Azizi Y2, 3 ; Aboutaleb N2, 3
Authors
Show Affiliations
Authors Affiliations
  1. 1. Department of Physiology, School of Medicine, Tehran University of Medical Sciences, Tehran, Iran
  2. 2. Physiology Research Center, Iran University of Medical Sciences, Tehran, Iran
  3. 3. Department of Physiology, Faculty of Medicine, Iran University of Medical Sciences, Tehran, Iran

Source: Molecular Biology Reports Published:2023


Abstract

The authors regret that there is one error image in Fig. 3A of this article. The current and corrected. Figure 3A can be seen as below. The corrections do not alter any findings and conclusions of this study. There are no additional text corrections in the article. The authors would like to apologize for any inconvenience caused. (Figure presented.) Immonohistochemical quantification of VEGF at 14 days after reperfusion. A Effects ELA on expression level of VEGF at 14 days after reperfusion (n = 5) groups, B quantified expression level of VEGF (***p < 0.001, and *p < 0.05 vs. Sham; #p < 0. 05, vs. MI, $p < 0. 05, vs. MI + Vehicle) (scale bar: low magnification: 100 μm and high magnification: 20 μm). Data are presented as mean ± SEM. © 2023, Springer Nature B.V.